Liver stiffness in chronic hepatitis C virus infection

1. THIELE M., KJAERGAARD M., THIELSEN P., KRAG A. Contemporary use of elastography in liver fibrosis and portal hypertension. Clin Physiol Funct Imaging 2017; 37:235-42.10.1111/cpf.12297Search in Google Scholar

2. GRUGUREVIC I., BOZIN T., MADIR A. Hepatitis C is now curable, but what happens with cirrhosis and portal hypertension afterwards? Clin Exp Hepatol 2017; 3:181-6.Search in Google Scholar

3. DOLMAZASHVILI E., ABUTIDZE A., CHKHARTISHVILI N., KARCHAVA M., SHARVADZE L., TSERTSVADZE T. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience. Eur J Gastroenterol Hepatol 2017; 29:1223-30.10.1097/MEG.0000000000000964Search in Google Scholar

4. TSOCHATZIS E.A., GERMANI G., HALL A., MANUOUSOU P., DHILLON A.P., BURROUGHS A.K. Noninvasive assessment of liver fibrosis: The need for better validation. Hepatology 2011; 53:1781-2.10.1002/hep.24271Search in Google Scholar

5. SINGH S.,MUIR A.J., DIETERICH D.T., FALCK-YTTER Y.T. American gastroenterological association institute technical review on the role of elastography in chronic liver diseases. Gastroenterology 2017; 152:1544-77.10.1053/j.gastro.2017.03.016Search in Google Scholar

6. SPOREA I., BOTA S., GRĂDINARU-TAŞCĂU O., ŞIRLI R., POPESCU A. Comparative study between two point Shear Wave Elastographic techniques: Acoustic Radiation Force Impulse (ARFI) elastography and ElastPQ. Med Ultrason 2014; 16:309-14.10.1016/S0168-8278(14)61176-4Search in Google Scholar

7. GRGUREVIC I., BOKUN T., BOZIN T., MATIC V., HABERLE S., SPOREA I. Non-invasive diagnosis of portal hypertension in cirrhosis using ultrasound based elastography. Med Ultrason 2017; 19:310-7.10.11152/mu-101928845498Search in Google Scholar

8. EUROPEAN ASDSOCIATION FOR THE STUDY OF THE LIVER, ASOCIATIÓN LATINOAMERICANA PARA EL ESTUDIO DEL HIGADO. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 2015; 63:237-64.10.1016/j.jhep.2015.04.00625911335Search in Google Scholar

9. CASTERA L., FORNS X., ALBERTI A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48:835-47.10.1016/j.jhep.2008.02.00818334275Search in Google Scholar

10. ROULOT D., CZERNICHOW S., LE CLESIAU H., COSTES J.L., VERGNAUD A.C., BEAUGRAND M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008; 48:606-13.10.1016/j.jhep.2007.11.02018222014Search in Google Scholar

11. KIM S.U., CHOI G.H., HAN W.K., KIM B.K., PARK J.Y., KIM DO Y., et al. What are ‘true normal’ liver stiffness values using FibroScan?: a prospective study in healthy living liver and kidney donors in South Korea. Liver Int 2010;30:268-74.10.1111/j.1478-3231.2009.02172.x19929903Search in Google Scholar

12. COLOMBO S., BELLOLI L., ZACCANELLI M., BADIA E., JAMOLETTI C., BUONOCORE M., et al. Normal liver stiffness and its determinants in healthy blood donors. Dig Liver Dis 2011;43:231-36.10.1016/j.dld.2010.07.00820817625Search in Google Scholar

13. DAS K., SARKAR R., AHMED S.M., MRIDHA A.R., MUKHERJEE P.S., DHALI G.K., et al. “Normal” liver stiffness measure (LSM) values are higher in both lean and obese individuals: a population-based study from a developing country. Hepatology 2012;55:584-93.10.1002/hep.2469421952989Search in Google Scholar

14. DIETRICH C.F., BAMBER J., BERZIGOTTI A., BOTA S., CANTISANI V., CASTERA L., et al. EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version). Ultraschall Med 2017;38:e16-e47.10.1055/s-0043-10395228407655Search in Google Scholar

15. MENDES L.C., FERREIRA P.A., MIOTTO N., ZANAGA L., GONÇALES E.S.L., PEDRO M.N., et al. Elastogram quality assessment score in vibration-controlled transient elastography: Diagnostic performance compared to digital morphometric analysis of liver biopsy in chronic hepatitis C. J Viral Hepat 2018;25:335-43.10.1111/jvh.1282229091321Search in Google Scholar

16. CONTI F., SERRA C., VUKOTIC R., FIORINI E., FELICANI C., MAZZOTTA E., et al. Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C. Liver Int 2017;37:187-95.10.1111/liv.1319727369740Search in Google Scholar

17. BOTA S, SPOREA I, PECK-RADOSAVLJEVIC M, SIRLI R, TANAKA H, IIJIMA H, et al. The influence of aminotransferase levels on liver stiffness assessed by Acoustic Radiation Force Impulse Elastography: a retrospective multicentre study. Dig Liver Dis 2013;45:762–8.10.1016/j.dld.2013.02.00823510533Search in Google Scholar

18. TSUKANO N., MIYASE S., SAEKI T., MIZOBE K., IWASHITA H., ARIMA N., et al. Usefulness of Virtual Touch Quantification for staging liver fibrosis in patients with hepatitis C, and the factors affecting liver stiffness measurement failure compared with liver biopsy. Hepatol Res 2018;48:373-82.10.1111/hepr.1304129226524Search in Google Scholar

19. SUMMERS J.A., RADHAKRISHAN M., MORRIS E., CHALKIDOU A., RUA T., PATEL A., et al. Virtual Touch™ quantification to diagnose and monitor liver fibrosis in hepatitis B and hepatitis C: A NICE medical technology guidance. Appl Health Econ Health Policy 2017;15:139-54.10.1007/s40258-016-0277-7534308327601240Search in Google Scholar

20. GHARIB A.M., HAN M.A.T., MEISSNER E.G., KLEINER D.E., ZHAO X., MCLAUGHLIN M., et al. Magnetic resonance elastography shear wave velocity correlates with liver fibrosis and hepatic venous pressure gradient in adults with advanced liver disease. Biomed Res Int 2017;2017:2067-479.10.1155/2017/2067479539643928480218Search in Google Scholar

21. THE AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES AND THE INFECTIOUS DISEASES SCOCIETY OF AMERICA. HCV Guidance: recommendations for testing, managing, and treating hepatitis C. www.HCVGuidance.org on August 13, 2018.Search in Google Scholar

22. ZIOL M., HANDRA-LUCA A., KETTANEH A., CHIRSTIDIS C., MAL F., KAZEMI F., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41:48-54.10.1002/hep.2050615690481Search in Google Scholar

23. AFDAHAL N.H., BACON B.R., PATEL K., LAWITZ E.J., GORDON S.C., NELSON D.R., et al. Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study. Clin Gastroenterol Hepatol 2015;13:772-9.10.1016/j.cgh.2014.12.01425528010Search in Google Scholar

24. CASTERA L., VERGNIOL J., FOUCHER J., LE B.B., CHANTELOUP E., HAASER M., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-50.10.1053/j.gastro.2004.11.01815685546Search in Google Scholar

25. CASTERA L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012;142:1293-302.10.1053/j.gastro.2012.02.01722537436Search in Google Scholar

26. BONDER A., AFDHAL N.H. Utilization of FibroScan in clinical practice. Curr Gastroenterol Rep 2014;16:372.10.1007/s11894-014-0372-624452634Search in Google Scholar

27. NAKAMURA Y., AIKATA H., FUKUHARA T., HONDA F., MORIO K., MORIO R., et al. Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection. Hepatol Res 2017;47:767-72.10.1111/hepr.1281527591427Search in Google Scholar

28. PaARANAGUÁ-VEZOZZO D.C., ANDRADE A., MAZO D.F., NUNES V., GUEDES A.L., RAGAZZO T.G., et al. Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C. World J Hepatol 2017;9:436-42.10.4254/wjh.v9.i8.436535576628357031Search in Google Scholar

29. DOLMAZASHVILI E., KARCHAVA M., ABUTIDZE A., SHARVADZE L., TSERTSVADZE T. Comparative study of FIB-4 index and transient elastography among patients with chronic hepatitis C virus infection in Georgia. Georgian Med News 2017;264:81-6.Search in Google Scholar

30. KJÆRGAARD M., THIELE M., JANSEN C., STÆHR MADSEN B., GÖRTZEN J., STRASSBURG C., et al. High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal. PLoS One 2017;12:e0173992.10.1371/journal.pone.0173992538030928376114Search in Google Scholar

31. DUCANCELLE A., LEROY V., VERGNIOL J., STURM N., LE BAIL B., ZARSKI J.P., et al. A single test combining blood markers and elastography is more accurate than other fibrosis tests in the main causes of chronic liver diseases. J Clin Gastroenterol 2017;51:639-49.10.1097/MCG.000000000000078828692443Search in Google Scholar

32. GANI R.A., HASAN I., SANITYOSO A., LESMANA C.R.A., URNIAWAN J., JASIRWAN C.O.M., et al. Evaluation of Acoustic Radiation Force Impulse (ARFI) for fibrosis staging in chronic liver diseases. Acta Med Indones 2017;49:128-35.Search in Google Scholar

33. PISCAGLIA F., SALVATORE V., MULAZZANI L., CANTISANI V., COLECCHIA A.,DI DONATO R., et al. Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study. Dig Liver Dis 2017;49:802-8.10.1016/j.dld.2017.03.00128365330Search in Google Scholar

34. MARE R., SPOREA I., LUPUŞORU R., ŞIRLI R., POPESCU A., DANILA M., et al. The value of ElastPQ for the evaluation of liver stiffness in patients with B and C chronic hepatopathies. Ultrasonics 2017;77:144-51.10.1016/j.ultras.2017.02.00528231488Search in Google Scholar

35. TSOCHATZIS E.A., GURUSAMY K.S., NTAOULA S., CHOLONGITAS E., DAVIDSON B.R., BURROUGHS A.K. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 2011;54:650-9.10.1016/j.jhep.2010.07.03321146892Search in Google Scholar

36. MOUSTAFA E.F., MAKHLOUF N., HASSANY S.M., HELMY A., NASR A., OTHMAN M., et al. Non-invasive assessment of liver fibrosis in patients with hepatitis C: Shear wave elastography and colour Doppler velocity profile technique versus liver biopsy. Arab J Gastroenterol 2017;18:6-12.10.1016/j.ajg.2017.01.00428262531Search in Google Scholar

37. GOMEZ-MORENO A.Z., PINEDA-TENOR D., JIMENEZ-SOUSA M.A., SÁNCHEZ-RUANO J.J., ARTAZA-VARASA T., SAURA-MONTALBAN J., et al. Liver stiffness measurement predicts liver-related events in patients with chronic hepatitis C: A retrospective study. PLoS One 2017;12:e0184404.10.1371/journal.pone.0184404558922128880930Search in Google Scholar

38. BOGLIONE L., CUSATO J., CARITI G., DI PERRI G., D’AVOLIO A. Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis C. Infect Genet Evol 2017;53:195-8.10.1016/j.meegid.2017.05.02628579527Search in Google Scholar

39. SCHWABL P., MANDORFER M., STEINER S., SCHEINER B., CHROMY D., HERAC M., et al. Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease. Aliment Pharmacol Ther 2017;45:139-49.10.1111/apt.1384427910154Search in Google Scholar

40. LENS S., ALVARADO E., MARIÑO Z., LONDOÑO M.C., LLOP E., MARTINEZ J., et al. Effects of all-oral anti-viral therapy on HVPG and systemic hemodynamics in patients with hepatitis C virus-associated cirrhosis. Gastroenterology 2017;153:1273-83.e1.10.1053/j.gastro.2017.07.01628734831Search in Google Scholar

41. TAG-ADEEN M., ALSENBESY M., GHWEIL A.A., ABD ELRAZEK M.A.H., ELGOHARY E.A., SALLAM M.M., et al. Liver stiffness measurement and spleen diameter as predictors for the presence of esophageal varices in chronic hepatitis C patients. Medicine (Baltimore) 2017;96:e8621.10.1097/MD.0000000000008621570482529145280Search in Google Scholar

42. SILVA M.J., BERNARDES C., PINTO J., LOUREIRO R., DUARTE P., MENDES M., et al. Baveno VI recommendation on avoidance of screening endoscopy in cirrhotic patients: Are we there yet? GE Port J Gastroenterol 2017;24:79-83.Search in Google Scholar

43. AUGUSTIN S., PONS M., MAURICE J.B., BUREAU C., STEFANESCU H., NEY M., et al. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology 2017;66:1980-8.10.1002/hep.2936328696510Search in Google Scholar

44. MARCONI C., BELLAN M., GIARDA P., MINISINI R., FAVRETTO S., BURLONE M.E., et al. Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C. Ann Gastroenterol 2017;30:675-81.10.20524/aog.2017.0190567028829118563Search in Google Scholar

45. BELLAN M., SAINAGHI P.P., MINH M.T., MINISINI R., MOLINARI L., BALDRIGHI M., et al. Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease. Biomark Med 2018;12:27-34.10.2217/bmm-2017-017129243516Search in Google Scholar

46. CHROMY D., SCHWABL P., BUCSICS T., SCHEINER B., STRASSI R., MAYER F., et al. Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients. Wien Klin Wochenschr 2018;130:105-14.10.1007/s00508-017-1231-x581610728744597Search in Google Scholar

47. CEPEDA J.A., THOMAS D.L., ASTEMBORSKI J., SULKOWSKI M.S., KIRK G.D., MEHTA S.H. Increased mortality among persons with chronic hepatitis C with moderate or severe liver disease: A cohort study. Clin Infect Dis 2017;65:235-43.10.1093/cid/cix207585045028329108Search in Google Scholar

48. FACCIORUSSO A., DEL PRETE V., TURCO A., BUCCINO R.V., NACCHIERO M.C., MUSCATIELLO N. Long-term liver stiffness assessment in HCV patients undergoing antiviral therapy: Results from a 5-year cohort study. J Gastroenterol Hepatol 2018;33:942-9.10.1111/jgh.1400828976021Search in Google Scholar

49. CHEN YI MEI S.L.G., THOMPSON A.J., CHRISTENSEN B., CUNNINGHAM G., MCDONALD L., et al. Sustained virological response halts fibrosis progression: A long-term follow-up study of people with chronic hepatitis C infection. PLoS One 2017;12:e0185609.10.1371/journal.pone.0185609565547329065124Search in Google Scholar

50. PONS M., SANTOS B., SIMÓN-TALERO M., VENTURA-COTS M., RIVEIRO-BARCIELA M., ESTEBAN R., et al. Rapid liver and spleen stiffness improvement in compensated advanced chronic liver disease patients treated with oral antivirals. Therap Adv Gastroenterol 2017;10:619-29.10.1177/1756283X17715198555718828835776Search in Google Scholar

51. TACHI Y., HIRAI T., KOJIMA Y., ISHIZU Y., HONDA T., KUZUYA T., et al. Liver stiffness reduction correlates with histological characteristics of hepatitis C patients with sustained virological response. Liver Int 2017;38:59-67.10.1111/liv.1348628557143Search in Google Scholar

52. CHAN J., GOELA N., ZHENG H., LAMMERT S., AJAYI T., FRICKER Z., et al. Direct-acting antiviral therapy for chronic HCV infection results in liver stiffness regression over 12 months post-treatment. Dig Dis Sci 2018;63:486-92.10.1007/s10620-017-4749-x28887750Search in Google Scholar

53. RAMOS H., LINARES P., BADIA E., MARTIN I., GÓMEZ J., ALMOHALLA C., et al. Asociación Castellano Y Leonesa de Hepatología ACyLHE. Interferon-free treatments in patients with hepatitis C genotype 1-4 infections in a real-world setting. World J Gastrointest Pharmacol Ther 2017;8:137-46.10.4292/wjgpt.v8.i2.137542111328533924Search in Google Scholar

54. ELSHARKAWY A., ALEM S.A., FOUARD R., EL RAZIKY M., EL AKEL W., ABDO M., et al. Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon. J Gastroenterol Hepatol 2017;32:1624-30.10.1111/jgh.1375828177543Search in Google Scholar

55. NEUKAM K., MORANO-AMADO L.E., RIVERO-JUÁREZ A., MACÍAS J., GRANADOS R., ROMERO-PALACIOS A., et al. Grupo de Estudio de Hepatitis Vírica, of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica: GEHEP- SEIMC and Grupo de Estudio de Hepatitis Vírica, of the Sociedad Andaluza de Enfermedades Infecciosas y Microbiología Clínica: HEPAVIR/Red de Investigación en SIDA (RIS-HEP07). Liver stiffness predicts the response to direct-acting antiviral-based therapy against chronic hepatitis C in cirrhotic patients. Eur J Clin Microbiol Infect Dis 2017;36:853-61.10.1007/s10096-016-2871-x28004322Search in Google Scholar

56. AKUTA N., SEZAKI H., SUZUKI F., KAWAMURA Y., HASAKA T., KOBAYASHI M., et al. Favorable efficacy of daclatasvir plus asunaprevir in treatment of elderly Japanese patients infected with HCV genotype 1b aged 70 and older. J Med Virol 2017;89:91-8.10.1002/jmv.2459227256744Search in Google Scholar

57. OGASAWARA N., KOBAYASHI M., AKUTA N., KOMINAMI Y., FUJIYAMA S., KAWAMURA Y., et al. Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1b. J Med Virol 2017;90:313-9.10.1002/jmv.2495028906010Search in Google Scholar

58. SINGH S., FACCIORUSSO A., LOOMBA R., FALCK-YTTER Y.T. Magnitude and kinetics of decrease in liver stiffness after antiviral therapy in patients with chronic hepatitis C: A systematic review and meta-analysis. Clin Gastroenterol Hepatol 2017;16:27-38.e4.10.1016/j.cgh.2017.04.038567136528479504Search in Google Scholar

59. TAG-ADEEN M., SABRA A.M., AKAZAWA Y., OHNITA K., NAKAO K. Impact ofhepatitis C virus genotype-4 eradication following direct acting antivirals on liver stiffness measurement. Hepat Med 2017;9:45-53.10.2147/HMER.S142600563857329062242Search in Google Scholar

60. JIMÉNEZ-SOUSA M.Á., GÓMEZ-MORENO A.Z., PINEDA-TENOR D., MEDRANO L.M., SÁNCHEZ-RUANO J.J., FERNÁNDEZ-RODRÍGUEZ A., et al. CXCL9-11polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study. Clin Transl Med 2017;6:26.Search in Google Scholar

61. STEINER S., BUCSICS T., SCHWABL P., MANDORFER M., SCHEINER B., AICHELBURG M.C., et al. Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna. Wien Klin Wochenschr 2017;129:517-26.10.1007/s00508-016-1162-y555284628130599Search in Google Scholar

62. SPOREA I., LUPUŞORU R., MARE R., POPESCU A., GHEORGHE L., IACOB S., et al. Dynamics of liver stiffness values by means of transient elastography in patients with HCV liver cirrhosis undergoing interferon free treatment. J Gastrointestin Liver Dis 2017;26:145-50.10.15403/jgld.2014.1121.262.dyn28617884Search in Google Scholar

63. FERRAIOLI G., MAIOCCHI L., LISSANDRIN R., TINELLI C., DE SILVESTRI A., FILICE C. on behalf of the Liver Fibrosis Study Group. Ruling-in and ruling-out significant fibrosis and cirrhosis in patients with chronic hepatitis C using a shear wave measurement method. J Gastrointestin Liver Dis 2017;26:139-43.10.15403/jgld.2014.1121.262.fer28617883Search in Google Scholar

64. TADA T., KUMADA T., TOYODA H., MIZUNO K., SONE Y., KATAOKA S., et al. Improvement of liver stiffness in patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response. J Gastroenterol Hepatol 2017;32:1982-8.10.1111/jgh.1378828299813Search in Google Scholar

65. SUDA T., OKAWA O., MASAOKA R., GYOTOKU Y., TOKUTOMI N., KATAYAMA Y., et al. Shear wave elastography in hepatitis C patients before and after antiviral therapy. World J Hepatol 2017;9:64-8.10.4254/wjh.v9.i1.64522027328105260Search in Google Scholar

66. DELLA-GUARDIA B., EVANGELISTA A.S., FELGA G.E., MARINS L.V., SALVALAGGIO P.R., ALMEIDA M.D. Diagnostic accuracy of transient elastography for detecting liver fibrosis after liver transplantation: A specific cut-off value is really needed? Dig Dis Sci 2017;62:264-72.Search in Google Scholar

67. KORDA D., LENARD Z.M., GERLEI Z., JAKAB Z., HABOUB-SANDIL A., WAGNER L., et al. Shear-wave elastography for the assessment of liver fibrosis in liver transplant recipients treated for hepatitis C virus recurrence. Eur J Gastroenterol Hepatol 2017;30:27-32.10.1097/MEG.000000000000100329049126Search in Google Scholar

68. MARTINI S., SACCO M., STRONA S., ARESE D., TANDOI F., DELL OLIO D., et al. Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis. Liver Int 2017;37:62-70.10.1111/liv.1319327344058Search in Google Scholar

69. MAURO E., CRESPO G., MONTIRONI C., LONDOÑO M.C., HERNÁNDEZ-GEA V., RUIZ P., et al. Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after SVR in recurrent hepatitis C. Hepatology 2018;67:1683-94.10.1002/hep.2955728960366Search in Google Scholar

70. BREGENZER A., CONEN A., KNUCKEL J., FRIEDL A., EIGENMANN. F, NÄF M., et al. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade. Swiss Med Wkly 2017;147:w14544.10.4414/smw.2017.1454429185250Search in Google Scholar

71. PARISI S.G., BASSO M., MENGOLI C., SCAGGIANTE R., ANDREIS S., FRANZETTI M.M., et al. Liver stiffness is not associated with short- and long-term plasma HIV RNA replication in immunocompetent patients with HIV infection and with HIV/HCV coinfection. Ann Gastroenterol 2017;30:534-1.10.20524/aog.2017.0175556677428845109Search in Google Scholar

72. ERMAN A., SATHYA A., NAM A., BIELOECKI J.M., FELD J.J., THEIN H.H., et al. Estimating chronic hepatitis C prognosis using transient elastography-based liver stiffness: A systematic review and meta-analysis. J Viral Hepat 2018;25:502-13.10.1111/jvh.1284629239068Search in Google Scholar

73. BRUNO G., SARACINO A., SCUDELLER L., FABRIZIO C., DELL’ACQUA R., MILANO E., et al. HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ? Int J Infect Dis 2017;62:64-71.Search in Google Scholar

74. MERCHANTE N., RIVERO-JUÁREZ A., TÉLLEZ F., MERINO D., RÍOS-VILLEGAS M.J., OJEDA-BURGOS G., et al.; Grupo Andaluz para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI). Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis. AIDS 2017;31:493-500.10.1097/QAD.000000000000135827922855Search in Google Scholar

75. XU H., KONG W., LIU L., CHI X., WANG X., WU R., et al. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C. BMC Gastroenterol 2017;17:62.10.1186/s12876-017-0618-5542437628486931Search in Google Scholar

76. SOTO M., SAMPIETRO-COLOM L., LASALVIA L., MIRA A., JIMÉNEZ W., NAVASA M. Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients. World J Gastroenterol 2017;23:3163-73.10.3748/wjg.v23.i17.3163542305328533673Search in Google Scholar

77. BACHOFNER J.A., VALLI P.V., KRÓGER A., BERGAMIN I., KÜNZLER P., BASERGA A., et al. Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index. Liver Int 2017;37:369-76.10.1111/liv.1325627678216Search in Google Scholar